Research Peptides in Somerville, MA

Shipping research peptides to Somerville

Peptides Factory Direct delivers third-party-tested research peptides to Somerville and the surrounding Massachusetts area. Orders ship as stable lyophilized vials ready for refrigerated storage and reconstitution in your lab. Whether you are part of a university group, a private research facility, or an independent Somerville researcher, every lot meets the same 99%+ purity target with a Certificate of Analysis on request, identity confirmed by mass spectrometry and purity quantified by HPLC.

Research peptide categories shipped to Somerville

Somerville researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.

Research peptides Somerville researchers request most

Below are the research peptides Somerville laboratories most often order. Each summary reflects the published research literature and is provided for laboratory context only, and every compound is research-use-only and is not for human or animal consumption.

VIP (Vasoactive Intestinal Peptide) research

VIP (vasoactive intestinal peptide) is a naturally occurring neuropeptide with broad signaling roles. It is studied in specialized research contexts including immune regulation and biotoxin-related research models.

Research mechanism. VIP research focuses on VPAC-receptor signaling, with interest in immune modulation, inflammation, and vascular endpoints.

Immune-regulation research. Studied for immune-signaling endpoints in models.

Inflammation research. Examined for anti-inflammatory signaling.

Biotoxin-illness research. Used in specialized research designs.

How it compares. VIP occupies a specialized research niche distinct from the structural, metabolic, and cognitive peptides.

Research pairings. Generally studied as a standalone specialized peptide.

Reference research values. Research references commonly cite 50 mcg four times daily (intranasal model) over extended study windows. Reference values only - a specialized compound.

Full VIP research profile → · Specialty peptides

Melanotan II (MT-II) research

Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone, a non-selective melanocortin agonist. It is studied for melanogenesis (pigmentation) and broader melanocortin endpoints in research models.

Research mechanism. Melanotan II activates multiple melanocortin receptors, driving melanin production in research models and engaging MC4R pathways relevant to appetite and libido endpoints.

Pigmentation research. Studied for melanogenesis and tanning endpoints in models.

Melanocortin-pathway research. A broad melanocortin agonist for receptor studies.

Appetite/libido signaling research. Examined for MC4R-mediated endpoints.

How it compares. Melanotan II is a non-selective agonist studied for pigmentation and broad melanocortin endpoints; Melanotan I (afamelanotide) is more selective; PT-141 is studied for sexual function.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 0.5-1 mg two to three times weekly. Reference values only.

Full Melanotan II research profile → · Sexual Health & Tanning peptides

Selank (anxiolytic nootropic) research

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin, developed in Russia. It is studied for anxiolytic (anti-anxiety) and cognitive endpoints without the sedation associated with classic anxiolytics.

Research mechanism. Selank research focuses on modulation of GABAergic and monoamine signaling and on brain-derived neurotrophic factor (BDNF) expression, with interest in anxiety and focus endpoints.

Anxiolytic research. Studied for anxiety endpoints without sedation in models.

Cognitive / focus research. Examined for attention and mental-clarity variables.

Neuroprotection and immune research. Its tuftsin lineage links it to immune-signaling studies.

How it compares. Selank is studied for anxiety endpoints where Semax is studied more for focus and BDNF; the two are complementary in cognitive research.

Research pairings. Selank + Semax is a common cognitive-research pairing (anxiety plus focus endpoints).

Reference research values. Research references commonly cite 250-500 mcg daily across 2-4 week cycles. Reference values only.

Full Selank research profile → · Cognitive & Neurological peptides

AOD 9604 (HGH Fragment 176-191) research

AOD 9604 is a modified fragment (residues 176-191) of human growth hormone, representing the region associated with fat metabolism. It is studied because it isolates the lipolytic portion of GH without the growth-signaling or glucose effects of the whole hormone.

Research mechanism. AOD 9604 research focuses on stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis without acting on the IGF-1 axis or blood glucose - the defining research feature.

Lipolysis research. Studied specifically for fat-metabolism endpoints in models.

Metabolic models without glucose effect. Useful where researchers want fat signaling isolated from blood-sugar variables.

Stubborn-fat research. Examined in models of resistant adipose tissue.

How it compares. Unlike GLP-1 peptides that act on appetite, AOD 9604 isolates the fat-metabolism portion of GH and does not affect blood sugar - a distinct research mechanism.

Research pairings. Sometimes studied alongside GH-secretagogues in metabolic research designs.

Reference research values. Research references commonly cite 300-600 mcg daily (often modeled in a fasted window) over 12-16 week study periods. Reference values only.

Full AOD 9604 research profile → · Fat Loss & Weight Management peptides

BPC-157 (Body Protection Compound 157) research

BPC-157 (Body Protection Compound 157) is a synthetic, stable pentadecapeptide of 15 amino acids derived from a partial sequence of a protein found in human gastric juice. In the research literature it is one of the most frequently studied "body protection" peptides because of its stability in gastric and aqueous environments and its broad activity across connective and epithelial tissue models.

Research mechanism. Research models associate BPC-157 with up-regulation of growth-factor signaling (notably the VEGFR2 pathway and FAK-paxillin signaling) that supports angiogenesis - the formation of new blood vessels - in injured tissue. It is also studied for modulation of the nitric-oxide system and for interaction with the gut-brain axis. These mechanisms are the subject of ongoing pre-clinical investigation and are reported in animal and in-vitro studies, not approved clinical indications.

Tendon and ligament repair research. A large share of BPC-157 literature examines tendon-to-bone healing, ligament models, and the tensile recovery of connective tissue after controlled injury. Researchers study it both locally (near a modeled injury site) and systemically because of its reported stability.

Gastrointestinal models. Because the parent sequence originates in gastric juice, BPC-157 is heavily studied in models of gut-lining integrity, ulceration, and inflammatory bowel conditions, where angiogenesis and epithelial repair are the variables of interest.

Inflammation and joint research. Anti-inflammatory signaling and joint-tissue models are a third common research theme, frequently paired with TB-500 in comparative stacking studies.

How it compares. Compared with TB-500, BPC-157 is studied as a faster-acting, more localized repair peptide; compared with GHK-Cu it targets connective and gut tissue rather than skin and hair. It is one of the most stability-tested peptides in the research catalog.

Research pairings. In the literature BPC-157 is most often studied alongside TB-500 (Thymosin Beta-4) for connective-tissue work, since the two are reported to act through complementary repair pathways - BPC-157 more locally and TB-500 through deeper, slower regeneration.

Reference research values. Research-reference protocols in the literature commonly cite 250-500 mcg once or twice daily over a 4-12 week study window, with some maintenance models at 250 mcg daily. These figures are reference values from published research only and are not dosing instructions for any living subject.

Full BPC-157 research profile → · Healing & Recovery peptides

GHK-Cu (Copper Peptide) research

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper). It is one of the most studied peptides in regenerative and dermatological research because of its role in copper transport and remodeling of the extracellular matrix.

Research mechanism. Research associates GHK-Cu with stimulation of collagen and elastin synthesis, antioxidant and anti-inflammatory signaling, and modulation of genes involved in tissue remodeling. The injectable form is studied separately from topical cosmetic applications.

Skin and tissue regeneration research. GHK-Cu is studied for wound-model healing, extracellular-matrix remodeling, and collagen synthesis.

Hair-follicle research. It appears frequently in hair-growth and follicle-signaling research models.

Anti-inflammatory and antioxidant studies. Its copper-transport role is studied for redox and inflammation endpoints.

How it compares. GHK-Cu targets skin, hair, and matrix research where BPC-157 and TB-500 target connective and muscle tissue, so it covers a distinct research niche.

Research pairings. In regenerative research GHK-Cu is sometimes paired with BPC-157 or TB-500 to model both structural and dermal repair.

Reference research values. Research references commonly cite 1-2 mg administered 3-5 times per week. Reference values only.

Full GHK-Cu research profile → · Healing & Recovery peptides

Hexarelin (potent GHRP) research

Hexarelin is a synthetic hexapeptide and one of the most potent growth-hormone-releasing peptides studied in research, with reported activity beyond GH release including cardiovascular-tissue signaling.

Research mechanism. Hexarelin strongly activates the GH-secretagogue receptor. Research notes desensitization with continuous exposure and increases in prolactin and cortisol, so cycled study designs are common.

Potent GH-release research. Studied where maximal GH-pulse stimulation is the variable.

Cardiac-tissue research. Examined for reported GH-independent cardiovascular signaling.

Cycled GHRP designs. Used in research that models receptor desensitization.

How it compares. Hexarelin is the most potent GHRP studied here but with the most off-target signaling and desensitization, contrasting with the gentler Ipamorelin.

Research pairings. Hexarelin is studied in cycled designs and monitored for prolactin/cortisol; it is rarely combined continuously with other GHRPs.

Reference research values. Research references commonly cite 100-200 mcg two to three times daily across 4-8 week cycles. Reference values only.

Full Hexarelin research profile → · Growth Hormone & Muscle peptides

PT-141 (Bremelanotide) research

PT-141 (Bremelanotide) is a synthetic melanocortin-receptor agonist derived from Melanotan II. It is studied for sexual-function endpoints through a central-nervous-system mechanism rather than a vascular one.

Research mechanism. PT-141 research focuses on activation of melanocortin receptors (notably MC4R) in the central nervous system, which is the distinguishing feature versus vascular mechanisms studied for other compounds.

Libido / sexual-function research. Studied for arousal endpoints in both male and female models via CNS signaling.

Melanocortin-pathway research. A model compound for MC4R signaling studies.

Centrally-mediated research. Used where a central rather than vascular mechanism is the variable.

How it compares. Unlike vascular-pathway compounds, PT-141 acts centrally; unlike Melanotan I/II it is studied primarily for sexual-function rather than tanning endpoints.

Research pairings. Generally studied as a standalone melanocortin agonist.

Reference research values. Research references commonly cite 1-2 mg administered 45-90 minutes before the modeled endpoint, used as-needed rather than daily. Reference values only.

Full PT-141 research profile → · Sexual Health & Tanning peptides

Tesamorelin (GHRH analog) research

Tesamorelin is a stabilized analog of growth-hormone-releasing hormone studied for its reported effect on visceral adipose tissue - the fat surrounding internal organs - in metabolic research models.

Research mechanism. Tesamorelin stimulates endogenous GH release like other GHRH analogs, with research focused specifically on visceral-fat endpoints rather than subcutaneous fat.

Visceral-fat research. Studied specifically for visceral adipose tissue endpoints.

Metabolic-health models. Examined for broader metabolic-syndrome research variables.

GHRH-axis research. Used as a GHRH analog in GH-release studies.

How it compares. Tesamorelin is studied for visceral fat specifically, distinguishing it from AOD 9604 (general lipolysis) and the GLP-1 peptides (appetite).

Research pairings. Studied as a standalone GHRH analog in metabolic research.

Reference research values. Research references commonly cite 1-2 mg daily. Reference values only.

Full Tesamorelin research profile → · Fat Loss & Weight Management peptides

IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) research

IGF-1 LR3 is a modified, long-acting analog of insulin-like growth factor 1, with an 83-amino-acid structure and a reduced affinity for binding proteins that gives it an extended active half-life in research models.

Research mechanism. IGF-1 LR3 research focuses on IGF-1-receptor activation driving cell proliferation, nutrient partitioning, and anabolic signaling. Its extended half-life is the defining research feature versus native IGF-1.

Anabolic / growth research. Among the most-studied peptides for cellular growth and protein-synthesis models.

Nutrient-partitioning research. Studied for its reported influence on substrate handling.

Recovery models. Examined for tissue-recovery endpoints in cycled research designs.

How it compares. Where GHRPs and GHRH analogs stimulate endogenous GH, IGF-1 LR3 supplies a downstream IGF signal directly, making it a distinct and more advanced research tool.

Research pairings. IGF-1 LR3 is studied in cycled designs rather than continuous use, sometimes following GH-secretagogue protocols.

Reference research values. Research references commonly cite 40-80 mcg daily in 4-6 week cycled study windows. Reference values only - an advanced research compound.

Full IGF-1 LR3 research profile → · Growth Hormone & Muscle peptides

Semax (BDNF nootropic) research

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia. It is studied for cognitive and neuroprotective endpoints and is one of the most-cited nootropic research peptides.

Research mechanism. Semax research focuses on up-regulation of BDNF and nerve-growth-factor signaling and on modulation of monoamine systems, with interest in learning, memory, and neuroprotection endpoints.

Cognitive / focus research. Studied for attention, learning, and memory endpoints.

Neuroprotection research. Examined in models of neural stress and recovery.

BDNF-signaling research. A model compound for neurotrophic-factor studies.

How it compares. Semax is studied more for focus and BDNF, Selank more for anxiety; N-Acetyl Semax Amidate is a more potent, longer-lasting analog.

Research pairings. Semax + Selank pairs focus and anxiety endpoints in cognitive research.

Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.

Full Semax research profile → · Cognitive & Neurological peptides

Ovagen (Organ Bioregulator) research

Ovagen is a peptide bioregulator from the Khavinson family, studied for reproductive and organ tissue-support concepts in research models. Peptide bioregulators are investigated for tissue-specific normalization of gene expression and protein synthesis.

Research mechanism. Ovagen research centers on tissue-specific peptide bioregulation - the concept that short peptides can support normal function and protein synthesis in their target organ tissue - within reproductive and organ-support research models.

Reproductive-tissue research. Studied for reproductive and organ tissue-support endpoints in models.

Organ-support research. Examined in bioregulator research focused on tissue normalization concepts.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator research framework.

How it compares. Ovagen is an organ/reproductive-tissue bioregulator, distinct from the vascular bioregulator Vesugen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Vesugen, Pinealon) in organ-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Ovagen research profile → · Specialty peptides

GHRP-2 (Growth Hormone Releasing Peptide-2) research

GHRP-2 is a synthetic hexapeptide growth-hormone secretagogue, studied as a middle ground between GHRP-6 (strong appetite signaling) and Ipamorelin (selective and clean).

Research mechanism. GHRP-2 activates the GH-secretagogue receptor for GH release, with a reportedly smaller appetite response than GHRP-6 and somewhat more than Ipamorelin in research models.

GH-release research. A potent GHRP for growth-hormone-pulse studies.

Body-composition models. Studied for downstream metabolic endpoints.

GHRH synergy research. Paired with CJC-1295 in stacking studies.

How it compares. GHRP-2 is studied as a balance between GHRP-6 potency/appetite and Ipamorelin selectivity.

Research pairings. GHRP-2 + CJC-1295 is a common research pairing; prolactin is monitored in models.

Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.

Full GHRP-2 research profile → · Growth Hormone & Muscle peptides

Tirzepatide (dual GLP-1/GIP agonist) research

Tirzepatide is a dual agonist that activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. It is one of the most-studied modern metabolic research peptides because it engages two incretin pathways at once.

Research mechanism. Tirzepatide research examines combined GLP-1 and GIP signaling on insulin response, satiety, and energy handling, with the dual-pathway mechanism the central research distinction.

Weight-management research. Studied for body-weight endpoints via dual incretin signaling.

Glucose-metabolism research. Examined for combined GLP-1/GIP metabolic effects.

Comparative incretin studies. Frequently compared with semaglutide.

How it compares. Tirzepatide adds GIP activity on top of GLP-1, which is the defining contrast with single-pathway semaglutide in research.

Research pairings. Studied as a standalone dual-agonist model or compared with semaglutide.

Reference research values. Research references describe a titration model from 2.5 mg up to 15 mg weekly over several weeks. Reference values only.

Full Tirzepatide research profile → · Fat Loss & Weight Management peptides

Research applications studied in Somerville

• Immune-regulation research (VIP). Studied for immune-signaling endpoints in models.
• Pigmentation research (Melanotan II). Studied for melanogenesis and tanning endpoints in models.
• Anxiolytic research (Selank). Studied for anxiety endpoints without sedation in models.
• Lipolysis research (AOD 9604). Studied specifically for fat-metabolism endpoints in models.
• Tendon and ligament repair research (BPC-157). A large share of BPC-157 literature examines tendon-to-bone healing, ligament models, and the tensile recovery of connective tissue after controlled injury. Researchers study it both locally (near a modeled injury site) and systemically because of its reported stability.

How Somerville researchers order and store material

Ordering for a Somerville lab is done in the Peptides Factory Direct portal, with one-time or recurring options and a checkout confirmation of laboratory research use. Material ships to Somerville as a lyophilized powder for refrigerated storage; after reconstitution keep it cold and use within the standard research window. Somerville researchers remain responsible for compliance with applicable law, and nothing supplied is for human or animal consumption. Open the order portal.

Why Somerville researchers choose Peptides Factory Direct

Research buyers in Somerville choose Peptides Factory Direct for one reason: verifiable quality. Every Somerville shipment carries a 99%+ purity target, a Certificate of Analysis on request, full lot tracking, and reference documentation for each compound. Fast domestic dispatch gets stable vials to Somerville labs without delay, and pricing and standards match every other US research address.

Nearby Massachusetts research areas we ship to

Frequently asked questions

All Massachusetts cities · All states · Research guides

External references: Massachusetts (Wikipedia) · U.S. Census Bureau